Impact of Evolocumab on the Effects of Clopidogrel in Patients With High On-Treatment Platelet Reactivity

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 259 participants.

Also called NCT03096288

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 259 participants (enrolled count) (from the registry)
Sponsor
  • Amgen Registry lists this organization as a collaborator
  • University of Florida Registry lists this organization as the lead sponsor
Registry
  • NCT NCT03096288
Other papers using this trial's data
  • Impact of evolocumab on the pharmacodynamic profiles of clopidogrel in patients with atherosclerotic cardiovascular disease: a randomised, double-blind, placebo-controlled study EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2023-03-20 DOI, PubMed 36602868, PMC10018291 Not in the PMC Open Access subset.

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT03096288. Randomized; quadruple masking; primary purpose treatment. Start 2017-10-03 (actual); primary completion 2020-11-02 (actual). Results posted on 2022-02-17.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Impact of Evolocumab on the Effects of Clopidogrel in Patients With High On-Treatment Platelet Reactivity
Condition
Atherosclerotic Cardiovascular Disease
Intervention (Drug)
Evolocumab
Intervention (Other)
Placebo
Lead sponsor
University of Florida (class: other)
Collaborator
Amgen (class: industry)

Record details

Record id
cardio:ct-nct03096288
Content hash
a0bb3cf77ef94bce76729be39996f35f550fd480d263067bb2280e87bce77cdc